ATE178058T1 - Verfahren zur herstellung von gewissen biphenyltetrazolderivaten - Google Patents

Verfahren zur herstellung von gewissen biphenyltetrazolderivaten

Info

Publication number
ATE178058T1
ATE178058T1 AT92309968T AT92309968T ATE178058T1 AT E178058 T1 ATE178058 T1 AT E178058T1 AT 92309968 T AT92309968 T AT 92309968T AT 92309968 T AT92309968 T AT 92309968T AT E178058 T1 ATE178058 T1 AT E178058T1
Authority
AT
Austria
Prior art keywords
biphenyltetrazole
derivatives
producing certain
disclosed
producing
Prior art date
Application number
AT92309968T
Other languages
English (en)
Inventor
William V Murray
Ronald Russell
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Application granted granted Critical
Publication of ATE178058T1 publication Critical patent/ATE178058T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92309968T 1991-11-01 1992-10-30 Verfahren zur herstellung von gewissen biphenyltetrazolderivaten ATE178058T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/786,666 US5252753A (en) 1991-11-01 1991-11-01 Process for the preparation of certain substituted biphenyl tetrazoles and compounds thereof

Publications (1)

Publication Number Publication Date
ATE178058T1 true ATE178058T1 (de) 1999-04-15

Family

ID=25139265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92309968T ATE178058T1 (de) 1991-11-01 1992-10-30 Verfahren zur herstellung von gewissen biphenyltetrazolderivaten

Country Status (11)

Country Link
US (1) US5252753A (de)
EP (1) EP0540356B1 (de)
JP (1) JP3145813B2 (de)
AT (1) ATE178058T1 (de)
AU (1) AU651014B2 (de)
CA (1) CA2081847A1 (de)
DE (1) DE69228727T2 (de)
DK (1) DK0540356T3 (de)
ES (1) ES2130161T3 (de)
GR (1) GR3030330T3 (de)
SG (1) SG47012A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
JP3501484B2 (ja) * 1992-12-17 2004-03-02 三共株式会社 ビフェニル誘導体
DK0788487T3 (da) * 1994-10-27 2001-10-22 Novartis Ag Fremgangsmåde til fremstilling af tetrazoler
FR2753705B1 (fr) 1996-09-20 1999-08-06 Procede pour la preparation de derives de 4-methyl-biphenyle
WO2002083127A1 (en) * 2001-04-09 2002-10-24 Tokai University Educational System Protein modification-inhibitory compositions
EP1571150A1 (de) * 2004-03-02 2005-09-07 Aventis Pharma Deutschland GmbH Prozess zur Herstellung von Tryptase Hemmstoffen
WO2006029057A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries, Ltd. Purification of olmesartan medoxomil
CN1993355A (zh) * 2004-09-02 2007-07-04 特瓦制药工业有限公司 奥美沙坦酯的纯化方法
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
EP1749828A1 (de) 2005-08-04 2007-02-07 Farmaprojects S.L. Verfahren zur Herstellung eines Angiotensin-II-Antagonisten
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX2009013293A (es) 2007-06-04 2010-02-15 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos.
EP2810951B1 (de) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2013537233A (ja) * 2010-09-17 2013-09-30 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド 脂肪酸合成酵素阻害剤
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
DE69024556T2 (de) * 1989-07-28 1996-10-17 Merck & Co Inc Substituierte Triazolinone, Triazolinthione und Triazolinimine als Angiotensin II-Antagonisten
DE122010000024I1 (de) * 1990-02-19 2010-07-08 Novartis Ag Acylverbindungen
US5039814A (en) * 1990-05-02 1991-08-13 Merck & Co., Inc. Ortho-lithiation process for the synthesis of 2-substituted 1-(tetrazol-5-yl)benzenes
AU653734B2 (en) 1990-06-19 1994-10-13 Meiji Seika Kabushiki Kaisha Substituted 4-biphenylmethoxypyridine derivatives
IE914572A1 (en) * 1991-01-17 1992-07-29 Zeneca Ltd Chemical process

Also Published As

Publication number Publication date
JPH05279350A (ja) 1993-10-26
CA2081847A1 (en) 1993-05-02
JP3145813B2 (ja) 2001-03-12
AU2740492A (en) 1993-05-06
EP0540356B1 (de) 1999-03-24
EP0540356A2 (de) 1993-05-05
SG47012A1 (en) 1998-03-20
EP0540356A3 (en) 1993-08-25
DE69228727T2 (de) 1999-08-19
ES2130161T3 (es) 1999-07-01
DK0540356T3 (da) 1999-10-11
US5252753A (en) 1993-10-12
GR3030330T3 (en) 1999-09-30
AU651014B2 (en) 1994-07-07
DE69228727D1 (de) 1999-04-29

Similar Documents

Publication Publication Date Title
DE69228727D1 (de) Verfahren zur Herstellung von gewissen Biphenyltetrazolderivaten
DE69210347D1 (de) Verfahren zur Herstellung von Zwischenprodukten zur Verwendung in der Herstellung von Alkoxyiminoacetamide
ATE227292T1 (de) Herstellung von camptothecinderivaten durch intramolekulare cyclisierung
ATE174903T1 (de) Neues verfahren zur herstellung von 7- (substituierten)-9-((substistuierter
ATE207884T1 (de) Verfahren zur herstellung von aminobenzol- derivaten
ZA888448B (en) Novel compounds
DE69222012D1 (de) Verfahren zur Herstellung von Alpha-Ketoamidderivaten
ATE127809T1 (de) Verfahren zur herstellung von verbindungen zur behandlung der gutartigen prostatahypertrophie.
ATE531702T1 (de) Verfahren zur herstellung von epoxytriazolderivat und zwischenprodukten dafür
ATE96464T1 (de) Verfahren zur herstellung von thiolen.
ATE221876T1 (de) Verfahren zur herstellung von zyklischen verbindungen
ATE272061T1 (de) Friedel-craft verfahren zur herstellung von thioxanthonen
DE69521012D1 (de) Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten
DE69632919D1 (de) Verfahren zur herstellung von 2-chlor-5-chloromethyl-thiazol
DE60335865D1 (de) Verfahren zur herstellung von cilostazol
DE60116201D1 (de) Verfahren zur Herstellung von Cephalosporin-Verbindungen und Zwischenprodukte für die Synthese dieser Verbindungen
ATE157971T1 (de) Verfahren zur herstellung von aminotriazin- derivaten
ATE335746T1 (de) Verfahren zur herstellung von epothilonen
ATE159246T1 (de) Verfahren zur herstellung von (s)-vinyl- und (s)- allenyl-gaba
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
ATE177737T1 (de) Verfahren zur herstellung von 5-arylhydantoin
ATE127784T1 (de) Verfahren und zwischenprodukte für die herstellung von 2-hydroxy-3-sulfido-3- phenylpropansäuren.
ATE116288T1 (de) Verfahren zur herstellung von sulfonylisocyanaten.
DE69418802D1 (de) Verfahren zur Herstellung von N-Alkylacetamiden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee